Testosterone Gel Recalled by Florida Pharmacy for Lack of Processing Control
The Medicine Shoppe Pharmacy in Florida is recalling Testosterone in Atrevis 50 mg/mL Gel due to a lack of processing control.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a moderate severity level involving temporary or medically reversible adverse health consequences, without reported serious injuries or deaths.
Plain-English summary
The Medicine Shoppe Pharmacy in Port Charlotte, Florida, is recalling Testosterone in Atrevis 50 mg/mL Gel 30 gm tubes. The recall was initiated due to a lack of processing control. The affected product is a prescription medication distributed in Florida.
The specific lot number is 44488, and the discard-by date is 8/22/2020. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions. The recall is limited to the specific lot identified in the notice.
The recalled product
- Product
- Testosterone in Atrevis 50 mg/mL Gel 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL
- Manufacturer
- The Medicine Shoppe Pharmacy
- Category
- Drug — Topical Gel
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 44488 Discard by: 8/22/2020
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 54 recalled by The Medicine Shoppe Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 54 products in this recall →Related recalls
Same manufacturer · The Medicine Shoppe Pharmacy
See all →- SevereBi-Est Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateDiethylstilbestrol Capsules Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateHydrocortisone Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateTestosterone Gel Recalled by Florida Pharmacy for Lack of Processing Control
FDA (Drugs) · 2020-04-22
- ModerateParegoric Alternate Elixir Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
Same hazard · processing control
See all →- ModerateErgotamine Tartrate and Caffeine Suppositories Recalled for Processing Control Issues
FDA (Drugs) · 2020-04-22
- ModerateEstradiol Vaginal Cream Recalled for Lack of Processing Control
FDA (Drugs) · 2020-04-22
Similar recalls
- ModerateTestosterone Cream Recalled for Lack of Processing Controls
FDA (Drugs) · 2019-02-06
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateTeva Recalls Testosterone Gel Due to High Out-of-Specification Assay Results
FDA (Drugs) · 2020-11-25
- SevereTestosterone Pellets Recalled for Potential Sterility Assurance Issues
FDA (Drugs) · 2015-09-23
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Testosterone and Anastrazole Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-09-23